Litcius/Paper detail

RaptGen-Assisted Generation of an RNA/DNA Hybrid Aptamer against SARS-CoV-2 Spike Protein

Tatsuo Adachi, Shigetaka Nakamura, Akiya Michishita, Daiki Kawahara, Mizuki Yamamoto, Michiaki Hamada, Yoshikazu Nakamura

2024Biochemistry11 citationsDOIOpen Access PDF

Abstract

Optimization of aptamers in length and chemistry is crucial for industrial applications. Here, we developed aptamers against the SARS-CoV-2 spike protein and achieved optimization with a deep-learning-based algorithm, RaptGen. We conducted a primer-less SELEX against the receptor binding domain (RBD) of the spike with an RNA/DNA hybrid library, and the resulting sequences were subjected to RaptGen analysis. Based on the sequence profiling by RaptGen, a short truncation aptamer of 26 nucleotides was obtained and further optimized by a chemical modification of relevant nucleotides. The resulting aptamer is bound to RBD not only of SARS-CoV-2 wildtype but also of its variants, SARS-CoV-1, and Middle East respiratory syndrome coronavirus (MERS-CoV). We concluded that the RaptGen-assisted discovery is efficient for developing optimized aptamers.

Topics & Concepts

AptamerSystematic evolution of ligands by exponential enrichmentSELEX Aptamer TechniqueCoronavirusRNADNASevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Computational biologyNucleotideDNA sequencingPrimer (cosmetics)Coronavirus disease 2019 (COVID-19)ChemistryBiologyMolecular biologyGeneGeneticsMedicineInfectious disease (medical specialty)PathologyOrganic chemistryDiseaseAdvanced biosensing and bioanalysis techniquesRNA Interference and Gene DeliveryRNA and protein synthesis mechanisms
RaptGen-Assisted Generation of an RNA/DNA Hybrid Aptamer against SARS-CoV-2 Spike Protein | Litcius